Protocol tips
Upstream tips |
Protocol tips |
Downstream tips |
|
Cells were grown in six-well culture dishes to 70–90% confluence. Plasmids (2 µg of pcDNA3.1 or pcDNA3.1 carrying indicated inserts and Mito-GFP; 2∶1 ratio) were co-transfected using LipofectAMINE and Plus reagents (Invitrogen) according to the manufacturer's instructions. siRNAs (25 nM) were transfected into HeLa cells using Dharmafect transfection reagent #1 (Dharmacon, Lafayette, CO) following the company's instructions. For some experiments, transfections were performed sequentially first with plasmid DNA followed 5 hours later by transfection of the ARL2 siRNA, to minimize cell toxicity evident from co-transfections. We consistently observed at least 70% transfection efficiency, using expression of fluorescence-tagged proteins to score |
|
Protocol tips |
Cells were grown in six-well culture dishes to 70–90% confluence. Plasmids (2 µg of pcDNA3.1 or pcDNA3.1 carrying indicated inserts and Mito-GFP; 2∶1 ratio) were co-transfected using LipofectAMINE and Plus reagents (Invitrogen) according to the manufacturer's instructions. siRNAs (25 nM) were transfected into HeLa cells using Dharmafect transfection reagent #1 (Dharmacon, Lafayette, CO) following the company's instructions. For some experiments, transfections were performed sequentially first with plasmid DNA followed 5 hours later by transfection of the ARL2 siRNA, to minimize cell toxicity evident from co-transfections. We consistently observed at least 70% transfection efficiency, using expression of fluorescence-tagged proteins to score |
Publication protocol
Cells were grown in six-well culture dishes to 70–90% confluence. Plasmids (2 µg of pcDNA3.1 or pcDNA3.1 carrying indicated inserts and Mito-GFP; 2∶1 ratio) were co-transfected using LipofectAMINE and Plus reagents (Invitrogen) according to the manufacturer's instructions. siRNAs (25 nM) were transfected into HeLa cells using Dharmafect transfection reagent #1 (Dharmacon, Lafayette, CO) following the company's instructions. For some experiments, transfections were performed sequentially first with plasmid DNA followed 5 hours later by transfection of the ARL2 siRNA, to minimize cell toxicity evident from co-transfections. We consistently observed at least 70% transfection efficiency, using expression of fluorescence-tagged proteins to score
Full paper
Login or
join for free to view the full paper.
Reviews
ON-TARGETplus Human ELMOD2 (255520) siRNA - SMARTpool from Horizon Discovery Ltd. has not yet been reviewed for this experiment
We'd love it if you would be the first to write a review!
Discussion
Start your discussion
Share your thoughts or question with experts in your field
Start a discussion
Papers
Check out relevant papers found by Labettor's AI that are relevant for performing siRNA / miRNA gene silencing Human - HeLa ELMOD2 using ON-TARGETplus Human ELMOD2 (255520) siRNA - SMARTpool from Horizon Discovery Ltd..
Manufacturer protocol
Download the product protocol from Horizon Discovery Ltd. for ON-TARGETplus Human ELMOD2 (255520) siRNA - SMARTpool below.
Download manufacturer protocol
Videos
Check out videos that might be relevant for performing siRNA / miRNA gene silencing Human - HeLa ELMOD2 using ON-TARGETplus Human ELMOD2 (255520) siRNA - SMARTpool from Horizon Discovery Ltd.. Please note that these videos are representative and steps or experiment specific processes must be kept in mind to expect desired results.
We haven't found any additional videos for this experiment / product combination yet.